Alice joined Hanson Wade in 2019 as a Conference Producer with a desire to begin a career that enabled application of her Biological Sciences degree in a more commercial setting. Alice is now a Portfolio Director within the Gene Therapy business unit. She is responsible for growing existing conferences that facilitate the development of safer, effective, and accessible gene therapies, as well as identifying new areas of opportunity that match unmet needs in the gene therapy market and beyond into other areas of life sciences.